Brighten Optix Corporation

TWO:6747 Taiwan Medical Devices
Market Cap
$163.60 Million
NT$5.41 Billion TWD
Market Cap Rank
#19645 Global
#980 in Taiwan
Share Price
NT$199.00
Change (1 day)
+0.00%
52-Week Range
NT$129.00 - NT$199.00
All Time High
NT$413.99
About

Brighten Optix Corporation researches, develops, manufactures, and sells contact lenses in Taiwan and internationally. The company offers orthokeratology, a non-invasive and reversible method of vision correction by using a hard contact lens to alter the shape of the front surface of the cornea; gas permeable lenses for single vison, multifocal, and irregular cornea and keratoconus correction, un… Read more

Brighten Optix Corporation (6747) - Total Liabilities

Latest total liabilities as of September 2025: NT$331.68 Million TWD

Based on the latest financial reports, Brighten Optix Corporation (6747) has total liabilities worth NT$331.68 Million TWD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Brighten Optix Corporation - Total Liabilities Trend (2017–2024)

This chart illustrates how Brighten Optix Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Brighten Optix Corporation Competitors by Total Liabilities

The table below lists competitors of Brighten Optix Corporation ranked by their total liabilities.

Company Country Total Liabilities
OPC Energy Ltd
TA:OPCE
Israel ILA5.76 Billion
Formosa Electronic Industries
TWO:8171
Taiwan NT$892.84 Million
Embassy Bancorp Inc
OTCQX:EMYB
USA $1.66 Billion
Samart Corporation Public Company Limited
BK:SAMART
Thailand ฿10.15 Billion
Seer Inc
NASDAQ:SEER
USA $36.79 Million
Soosan Industries Co. Ltd.
KO:126720
Korea ₩114.53 Billion
Atland S.A.
PA:ATLD
France €246.97 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Brighten Optix Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.59 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.29 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Brighten Optix Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Brighten Optix Corporation (2017–2024)

The table below shows the annual total liabilities of Brighten Optix Corporation from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 NT$180.47 Million -11.71%
2023-12-31 NT$204.40 Million +5.21%
2022-12-31 NT$194.28 Million +1.18%
2021-12-31 NT$192.02 Million +34.45%
2020-12-31 NT$142.82 Million +1.43%
2019-12-31 NT$140.81 Million -21.31%
2018-12-31 NT$178.95 Million -40.12%
2017-12-31 NT$298.84 Million --